Form D · Pharmaceuticals
VasoRx, Inc.
Santa Barbara, CA · CIK 0001737375
Offering snapshot reported Mar 4, 2019 · SEC filing
- Reported sold
- $3.1M Offering amount: $3.1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 10, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 4, 2019 | Initial | $3,100,000 | No comparison | 1 | SEC filing |
| Apr 13, 2018 | Initial | $1,600,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-334024
Source: Form D, filed Mar 4, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Krisztina Zsebo | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
909 Aleeda Lane
Santa Barbara, CA, 93108
Santa Barbara, CA, 93108